US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development.
Saved in:
| Title: | US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development. |
|---|---|
| Authors: | Morant AV; Regulatory Science & Advocacy, H. Lundbeck A/S, Copenhagen, Denmark., Vestergaard HT; Regulatory Strategy, H. Lundbeck A/S, Copenhagen, Denmark., Lassen AB; Patient Insights, H. Lundbeck A/S, Copenhagen, Denmark., Navikas V; Medical Affairs, H. Lundbeck A/S, Copenhagen, Denmark. |
| Source: | Clinical and translational science [Clin Transl Sci] 2020 Jul; Vol. 13 (4), pp. 652-664. Date of Electronic Publication: 2020 Mar 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
